Section on Advances in Therapeutics and Technology Program

查看最新文献

301

Section on Advances in Therapeutics and Technology Program - 最新文献

Dupilumab Was Well Tolerated and Significantly Improved Atopic Dermatitis in Children Aged ≥ 6 to < 12 Years: Results From the LIBERTY AD PEDS Phase 3 Trial

Pub Date : 2021-02-24 DOI: 10.1542/PEDS.147.3_MEETINGABSTRACT.300 D. Marcoux, Jashin J. Wu, B. Shumel, Y. Ohya, A. Zhang, Zhen Chen

Characteristics and Outcomes of Pediatric Polybacterial Conjunctivitis Infections in Studies with Besifloxacin Ophthalmic Suspension 0.6%

Pub Date : 2021-02-24 DOI: 10.1542/PEDS.147.3_MEETINGABSTRACT.296 J. Blondeau, C. Sanfilippo, H. Proskin, H. DeCory

Efficacy And Safety Of Crisaborole In Patients Aged 3 Months To 17 Years With Mild-To-Moderate Atopic Dermatitis

Pub Date : 2021-02-24 DOI: 10.1542/PEDS.147.3_MEETINGABSTRACT.302 John C. Su, L. Spelman, L. Eichenfield, L. Gold, A. Cha, D. Graham, L. Takiya, J. Werth, C. Zang, B. Vlahos

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。